- Targeting the Transcription Factors of ROS Tumorigenic Pathways as a Therapeutic Strategy in Cancer
Kannappan Sriramajayam et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef - Antiinflammatory and antioxidant effects of gemcitabinein collagen-induced arthritis model
Adile Ferda DAĞLI et al, 2017, TURKISH JOURNAL OF MEDICAL SCIENCES CrossRef - Mechanisms of Cancer Cell Death: Therapeutic Implications for Pancreatic Ductal Adenocarcinoma
Hannah Pook et al, 2021, Cancers CrossRef - Cellular and molecular responses to acute cocaine treatment in neuronal-like N2a cells: potential mechanism for its resistance in cell death
Ramesh B. Badisa et al, 2018, Cell Death Discovery CrossRef - The Crosstalk between Nrf2 and TGF-β1 in the Epithelial-Mesenchymal Transition of Pancreatic Duct Epithelial Cells
Sarah Arfmann-Knübel et al, 2015, PLOS ONE CrossRef - ROS Modulator Molecules with Therapeutic Potential in Cancers Treatments
Carole Nicco et al, 2017, Molecules CrossRef - Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication
Olivia Perwitasari et al, 2015, ASSAY and Drug Development Technologies CrossRef - Dual inhibition of EGFR and MET induces synthetic lethality in triple-negative breast cancer cells through downregulation of ribosomal protein S6
YONG WEON YI et al, 2015, International Journal of Oncology CrossRef - Ribosomal Protein S6: A Potential Therapeutic Target against Cancer?
Yong Weon Yi et al, 2021, International Journal of Molecular Sciences CrossRef - Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity
Dora Posfai et al, 2018, Antimicrobial Agents and Chemotherapy CrossRef - PIK Your Poison: The Effects of Combining PI3K and CDK Inhibitors against Metastatic Cutaneous Squamous Cell Carcinoma In Vitro
Jay R. Perry et al, 2024, Cancers CrossRef - Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
Jianhui Yang et al, 2021, International Journal of Molecular Sciences CrossRef - Therapeutic Targeting of the NRF2 Signaling Pathway in Cancer
Pelin Telkoparan-Akillilar et al, 2021, Molecules CrossRef - Potential Applications of NRF2 Inhibitors in Cancer Therapy
Emiliano Panieri et al, 2019, Oxidative Medicine and Cellular Longevity CrossRef - Inhibition of the NRF2/KEAP1 Axis: A Promising Therapeutic Strategy to Alter Redox Balance of Cancer Cells
Emiliano Panieri et al, 2021, Antioxidants & Redox Signaling CrossRef - Comparative analysis of NRF2-responsive gene expression in AcPC-1 pancreatic cancer cell line
Yong Weon Yi et al, 2015, Genes & Genomics CrossRef - Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
Xupeng Bai et al, 2016, Drug Metabolism Reviews CrossRef - Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231
Chao Meng et al, 2017, Oncology Reports CrossRef - Nrf2-Mediated Antioxidant Response and Drug Efflux Transporters Upregulation as Possible Mechanisms of Resistance in Photodynamic Therapy of Cancers
Olawale Ajuwon et al, 2024, OncoTargets and Therapy CrossRef - Keap1–Nrf2 signalling in pancreatic cancer
Alastair J. Hayes et al, 2015, The International Journal of Biochemistry & Cell Biology CrossRef - Brusatol Enhances the Chemotherapy Efficacy of Gemcitabine in Pancreatic Cancer via the Nrf2 Signalling Pathway
Yukai Xiang et al, 2018, Oxidative Medicine and Cellular Longevity CrossRef - Oxidative Stress and Cancer Heterogeneity Orchestrate NRF2 Roles Relevant for Therapy Response
Koraljka Gall Trošelj et al, 2022, Molecules CrossRef - iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding
Wenjie Ge et al, 2017, Cancer Cell CrossRef - Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches
Ming Gu et al, 2024, Cancer Letters CrossRef - HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction
Hyo Jin Kang et al, 2014, Scientific Reports CrossRef - Precision Targeting Strategies in Pancreatic Cancer: The Role of Tumor Microenvironment
Nikolaos Vitorakis et al, 2024, Cancers CrossRef - Dual Inhibition of AKT and MEK Pathways Potentiates the Anti-Cancer Effect of Gefitinib in Triple-Negative Breast Cancer Cells
Kyu Sic You et al, 2021, Cancers CrossRef - NRF2 inhibitors: Recent progress, future design and therapeutic potential
Bingbing Lv et al, 2024, European Journal of Medicinal Chemistry CrossRef - Signaling pathways and their potential therapeutic utility in esophageal squamous cell carcinoma
L. K. Kadian et al, 2022, Clinical and Translational Oncology CrossRef - NFR2/ABC transporter axis in drug resistance of breast cancer cells
Zinat Sargazi et al, 2023, Molecular Biology Reports CrossRef - The RSL3 Induction of KLK Lung Adenocarcinoma Cell Ferroptosis by Inhibition of USP11 Activity and the NRF2-GSH Axis
Wenlong Zhang et al, 2022, Cancers CrossRef - Molecular Therapeutics of Pancreatic Ductal Adenocarcinoma: Targeted Pathways and the Role of Cancer Stem Cells
Andrei-Florian Stoica et al, 2020, Trends in Pharmacological Sciences CrossRef - Brucein D augments the chemosensitivity of gemcitabine in pancreatic cancer via inhibiting the Nrf2 pathway
Juan Zhang et al, 2022, Journal of Experimental & Clinical Cancer Research CrossRef - The Role of Nrf2 in the Regulation of Mitochondrial Function and Ferroptosis in Pancreatic Cancer
Dinara Baiskhanova et al, 2024, Antioxidants CrossRef - Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells
Hong-Quan Duong et al, 2017, Antioxidants CrossRef - Dual roles and therapeutic potential of Keap1-Nrf2 pathway in pancreatic cancer: a systematic review
Jiang-Jiang Qin et al, 2019, Cell Communication and Signaling CrossRef - Role of Nrf2 in Pancreatic Cancer
Marta Cykowiak et al, 2021, Antioxidants CrossRef - Isoform-Selective PI3K Inhibitors for Various Diseases
Rammohan R.Y. Bheemanaboina, 2020, Current Topics in Medicinal Chemistry CrossRef - Nuclear Factor Erythroid 2-Related Factor 2 in Regulating Cancer Metabolism
Katarína Smolková et al, 2020, Antioxidants & Redox Signaling CrossRef - BMP8A promotes survival and drug resistance via Nrf2/TRIM24 signaling pathway in clear cell renal cell carcinoma
Yi‐peng Yu et al, 2020, Cancer Science CrossRef - Liver and gastrointestinal cancers
Jose J.G. Marin et al, 2020, Drug Efflux Pumps in Cancer Resistance Pathways: From Molecular Recognition and Characterization to Possible Inhibition Strategies in Chemotherapy CrossRef - Brusatol: A potential sensitizing agent for cancer therapy from Brucea javanica
Ting He et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Gene Expression Signatures Identify Novel Therapeutics for Metastatic Pancreatic Neuroendocrine Tumors
Aaron T. Scott et al, 2020, Clinical Cancer Research CrossRef - Organismal roles for the PI3Kα and β isoforms: their specificity, redundancy or cooperation is context-dependent
Silvia Arcucci et al, 2021, Biochemical Journal CrossRef - Mechanisms of Overcoming Intrinsic Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma through the Redox Modulation
Huai-Qiang Ju et al, 2015, Molecular Cancer Therapeutics CrossRef - Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis
Qiqing Sun et al, 2020, Oncogene CrossRef - Targeting the Transcription Factors of ROS Tumorigenic Pathways as a Therapeutic Strategy in Cancer
Kannappan Sriramajayam et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef - Knockdown of a novel lincRNA AATBC suppresses proliferation and induces apoptosis in bladder cancer
Fengjin Zhao et al, 2015, Oncotarget CrossRef - Kaempferol inhibits Nrf2 signalling pathway via downregulation of Nrf2 mRNA and induces apoptosis in NSCLC cells
Chandrani Fouzder et al, 2021, Archives of Biochemistry and Biophysics CrossRef - Compound NSC84167 selectively targets NRF2-activated pancreatic cancer by inhibiting asparagine synthesis pathway
Bingbing Dai et al, 2021, Cell Death & Disease CrossRef